Bridging clinical and molecular endocrinology The Molecular Endocrinology Department (KMEB) was established in 2001 as the cellular and molecular research unit of Department of Endocrinology, University Hospital, Odense. Endocrine diseases influence molecules, cells, animals and humans as well as populations and ecosystems. The main focus of KMEB is to integrate clinical endocrinology research with basic molecular and cellular approaches, to study clinically relevant research questions at the cellular and molecular levels and most importantly to to develop new therapies to be tested in clinical trials. The department international research scientists investigate causes, consequences and treatments of endocrine diseases by incorporating information generated across multiple research methodologies including cutting-edge stem cell and other cellular and molecular studies, mouse genetic models, high resolution imaging, bioinformatics and observational clinical studies and interventional clinical trials.
| Website | https://www.sdu.dk/en/forskning/kmeb |
| Revenue | $498.5 million |
| Employees | 11 (7 on RocketReach) |
| Founded | 2001 |
| Industry | Research Services |
| Keywords | Hormone Research, Clinical Endocrinology, Endocrine Disorders, Endocrine Diseases, Cellular Research, Endocrine System, Receptor Research, Hormone Therapy, Biomedical Research, Diabetes Research, Thyroid Disorders, Metabolic Disorders, Endocrine Testing, Medical Research, Adrenal Disorders, Pituitary Disorders, Clinical Trials, Drug Discovery |
| Competitors | Edelman, McKinsey & Company, Boston Consulting Group (BCG), Deloitte, Accenture, PwC, KPMG In Pakistan, EY, Bain & Company, IBM +42 more (view full list) |
Looking for a particular KMEB employee's phone or email?
The KMEB annual revenue was $498.5 million in 2026.
7 people are employed at KMEB.